Successive purchases and deliveries of medicines

for the Wielkopolska Rheumatology Centre SP SZOZ in Śrem

a detailed description of the order is included in Annexes 2.1-2.25 to the SWZ

Pharmaceutical products - medicines

A detailed description of the subject of the contract is included in Annex 2.1. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — TOFACITINIB

A detailed description of the subject of the contract is included in Annex 2.10. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — BARICYTINIB

A detailed description of the subject of the contract is included in Annex 2.11. to the SWZ

Successive purchases and delivery of medicines to the drug program — SEKUKINUMAB

A detailed description of the subject of the contract is included in Annex 2.12. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — UPADACITINIB

A detailed description of the subject of the contract is included in Annex 2.13. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — IKSEKIZUMAB

A detailed description of the subject of the contract is included in Annex 2.14. to the SWZ

Successive purchases and deliveries of medicines for the drug programme – NINTEDANIB

A detailed description of the subject of the contract is included in Annex 2.15. to the SWZ

Successive purchases and deliveries of medicines for the drug programme – GUSELKUMAB

A detailed description of the subject of the contract is included in Annex No. 2.16. to the SWZ

Successive purchases and deliveries of medicines for the drug programme – FILGOTINIB

A detailed description of the subject of the contract is included in Annex 2.17. to the SWZ

Successive purchases and deliveries of medicines for the drug program – RISANKIZUMAB

A detailed description of the subject of the contract is included in Annex 2.18. to the SWZ

Successive purchases and deliveries of medicines for the drug program – GUSELKUMAB in the period from 1.11.2023 to 31.12.2023

A detailed description of the subject of the contract is included in Annex 2.19. to the SWZ

Successive purchases and deliveries of infusion fluids

A detailed description of the subject of the contract is included in Annex 2.2. to the SWZ

Successive purchases and deliveries of medicines to the drug program – FILGOTINIB in the period from 1.11.2023 to 31.12.2023

A detailed description of the subject of the contract is included in Annex 2.20. to the SWZ

Successive purchases and deliveries of medicines to the drug program – RISANKIZUMAB in the period from 1.11.2023 to 31.12.2023

A detailed description of the subject of the contract is included in Annex 2.21. to the SWZ

Successive purchases and deliveries of medicines for the drug program – RITAUXIMAB in the period from 1.11.2023 to 31.12.2023

A detailed description of the subject of the contract is included in Annex 2.22. to the SWZ

Successive purchases and deliveries of medicines to the drug program – ANIFROLUMAB in the period from 1.11.2023 to 31.12.2023

A detailed description of the subject of the contract is included in Annex 2.23. to the SWZ

1. Successive purchases and deliveries of medicines for the drug program – ANIFROLUMAB.

A detailed description of the subject of the contract is included in Annex 2.24. to the SWZ

Successive purchases and deliveries of medicines for the drug program – ANAKINRA.

A detailed description of the subject of the contract is included in Annex 2.25. to the SWZ

Successive purchases and deliveries of medicines for the drug program – TOCILIZUMAB

A detailed description of the subject of the contract is included in Annex 2.3. to the SWZ

Successive purchases and deliveries of medicines for the drug program – ETARNECEPT.

A detailed description of the subject of the contract is included in Annex 2.4. to the SWZ

Successive purchases and deliveries of medicines for the drug program – CERTOLIZUMAB

A detailed description of the subject of the contract is included in Annex 2.5. to the SWZ

Successive purchases and deliveries of medicines for the drug program – ADALIMUMAB

A detailed description of the subject of the contract is included in Annex 2.6. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — RITUXYMAB

A detailed description of the subject of the contract is included in Annex 2.7. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — INFLIXIMAB

A detailed description of the subject of the contract is included in Annex 2.8. to the SWZ

Successive Drug Purchases and Supplies to Drug Program — GOLIMUMAB

A detailed description of the subject of the contract is included in Annex 2.9. to the SWZ